Normal view
-
cs.AI, q-bio.NC updates on arXiv.org
-
KT4EQG: Personalized Exercise Question Generation via Knowledge Tracing
arXiv:2605.23933v1 Announce Type: cross Abstract: Educational Question Generation (EQG) aims to synthesize customized exercise questions that enhance student learning. An effective EQG system should ideally personalize questions for each student by modeling the student's knowledge state and generating questions that provide the greatest learning benefit. However, few existing EQG approaches are able to achieve such fine-grained personalization. In this paper, we explore how EQG can benefit from
-
cs.AI, q-bio.NC updates on arXiv.org
-
DBPnet: Damper Characteristics-Based Bayesian Physics-Informed Neural Network for Wheel Load Estimation
arXiv:2605.24860v1 Announce Type: cross Abstract: Advanced driver assistance systems (ADAS) play an important role in modern automotive intelligence, significantly enhancing vehicle safety and stability. The performance of ADAS critically relies on accurate and reliable vehicle state estimation, particularly from vehicle dynamic sensors. Among these signals, wheel load is a key variable for chassis control and safety-critical functions, yet it remains difficult to estimate robustly due to compl
DBPnet: Damper Characteristics-Based Bayesian Physics-Informed Neural Network for Wheel Load Estimation
-
cs.AI, q-bio.NC updates on arXiv.org
-
Hide to Guide: Learning via Semantic Masking
arXiv:2605.25198v1 Announce Type: cross Abstract: Reinforcement learning with verifiable rewards (RLVR) has become a powerful paradigm for improving language models on reasoning-intensive tasks, but its effectiveness is often limited by exploration. For example, models often fail on hard problems, leaving little useful reward signal. External expert traces offer a natural source of guidance, yet they may also expose reward-relevant content along the critical path to the verifier target, such as
Hide to Guide: Learning via Semantic Masking
-
cs.AI, q-bio.NC updates on arXiv.org
-
Benchmarking Pathology Foundation Models for Spatial Domain Understanding
arXiv:2605.25764v1 Announce Type: cross Abstract: Pathology foundation models (PFMs) have emerged as a core approach for learning transferable representations from whole slide images (WSIs), and they are typically benchmarked through downstream clinical endpoints. While such task level evaluations are indispensable, they offer limited insight into what the representations themselves encode, particularly whether PFM embeddings can distinguish meaningful tissue regions and capture their spatial r
Benchmarking Pathology Foundation Models for Spatial Domain Understanding
-
cs.AI, q-bio.NC updates on arXiv.org
-
Topology-Driven Transferability Estimation of Medical Foundation Models for Segmentation
arXiv:2602.23916v2 Announce Type: replace-cross Abstract: The advent of large-scale self-supervised learning (SSL) has produced a vast zoo of medical foundation models. However, selecting optimal medical foundation models for specific segmentation tasks remains a computational bottleneck. Existing Transferability Estimation (TE) metrics, primarily designed for classification, rely on global statistical assumptions and fail to capture the topological complexity essential for dense prediction. We
Topology-Driven Transferability Estimation of Medical Foundation Models for Segmentation
-
Omics in Hepatocellular
-
Integrative multi-omics and experimental validation reveal UBE2C as a central hub gene and prognostic biomarker in hepatocellular carcinoma
Int Immunopharmacol. 2026 May 19;183:116866. doi: 10.1016/j.intimp.2026.116866. Online ahead of print.ABSTRACTHepatocellular carcinoma (HCC) is a lethal malignancy with a high recurrence rate and limited treatment options. Ubiquitin-conjugating enzyme E2 C (UBE2C) is implicated in various cancers, yet its impact on the HCC immune landscape remains incompletely understood. Herein, hub genes in HCC were identified, by integrating co-expression networks and protein-protein interaction analyses, fro
Integrative multi-omics and experimental validation reveal UBE2C as a central hub gene and prognostic biomarker in hepatocellular carcinoma
Int Immunopharmacol. 2026 May 19;183:116866. doi: 10.1016/j.intimp.2026.116866. Online ahead of print.
ABSTRACT
Hepatocellular carcinoma (HCC) is a lethal malignancy with a high recurrence rate and limited treatment options. Ubiquitin-conjugating enzyme E2 C (UBE2C) is implicated in various cancers, yet its impact on the HCC immune landscape remains incompletely understood. Herein, hub genes in HCC were identified, by integrating co-expression networks and protein-protein interaction analyses, from the TCGA, GEO, and CPTAC databases. Their expression was analysed using a single-cell transcriptomic database and verified in HCC tissues and cell lines via quantitative reverse transcription-PCR and immunoblotting. Functional roles of UBE2C were assessed using in vitro knockdown experiments and an in vivo subcutaneous tumour model. The tumour immune microenvironment was profiled using spatial transcriptomics, RNA-seq data, and ssGSEA. A prognostic nomogram was constructed based on multivariate Cox regression. UBE2C was identified as a significantly upregulated hub gene in HCC. Single-cell RNA-seq revealed predominant expression of UBE2C in hepatocytes, with dynamic upregulation along differentiation trajectories. UBE2C knockdown suppressed proliferation, induced apoptosis, and inhibited tumour growth. Spatial transcriptomics highlighted UBE2C-high regions within proliferative niches exhibiting immunosuppressive traits-including TGFB1 enrichment, impaired CXCL9-CXCR3 signalling, and exclusion of cytotoxic T cells-which were reduced in immunotherapy responders. UBE2C expression correlated with immune checkpoint genes and specific immune cell subsets. A UBE2C-based nomogram integrating T stage and tumour stage robustly predicted patient survival, and miR-300 and miR-381-3p were identified as potential upstream regulators. These findings establish UBE2C as a key driver of HCC progression and a biomarker for prognosis and immunotherapy stratification.
PMID:42155390 | DOI:10.1016/j.intimp.2026.116866